PEspeaks

May 21, 2015
After hearing “strong views” on the issue, FDA is expected to release biosimilar-naming guidance later this year.
May 20, 2015
Current clinical trials are regarded as “too slow, too expensive, not reliable, and not designed to answer the important questions,” according to FDA’s new deputy commissioner for medical products &tobacco, Robert Califf.
May 19, 2015
NICE's proposed Innovation Office emerges with a new name. Leela Barham reports.
May 18, 2015
Reflector looks at the revitalized European Union directive on patients’ rights in cross-border healthcare.
May 18, 2015
Cures and therapies with curative intent are here in hepatitis C and are imminent in other serious diseases. So what does this mean for pharma stakeholders, from suppliers to patients, asks Mike Rutstein.
May 17, 2015
Following the Conservatives surprise majority win in the UK election, Leela Barham asks what does it mean for pharma?
May 14, 2015
Casey McDonald reports on yesterday's Healthcare Businesswoman’s Association's Woman of the Year award ceremony in New York
May 13, 2015
If you haven’t been following the Orexigen story, on Tuesday, Twitter was an excellent venue to get caught up on the drama, writes Casey McDonald.
May 12, 2015
William Looney reports on last week's Global Educators Network for Health Care Innovation Education meeting, focused on shared learning and best practices to drive reforms in both the public and private sectors.
May 12, 2015
Casy McDonald looks forward to CBI's Patient Adherence and Access Summit in Philadelphia.